ADAG
Adagene Inc.
There isn't enough reported data to score ADAG yet.
ADAG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
ADAG's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
ADAG PE Valuation
ADAG has no meaningful PE right now: it lost money over the past year.
ADAG Forward outlook
There aren't enough analyst estimates for ADAG to show an outlook.
ADAG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.30 | +$0.46 |
| Q2 2025 | -$0.51 | +$0.39 |
| Q4 2024 | -$0.76 | -$0.22 |
| Q2 2024 | -$0.90 | +$0.16 |
| Q1 2024 | -$0.72 | +$1.64 |
| Q4 2023 | -$0.54 | +$2.45 |
| Q3 2023 | -$0.80 | +$2.74 |
| Q2 2023 | -$1.06 | +$2.52 |
ADAG is still losing money, but far less than before: $0.30 per share over the past year, against $3.58 at its worst in mid-2022.
ADAG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $407.9K | -85% |
| Q3 2023 | $407.9K | -85% |
| Q2 2023 | $8.6M | +120% |
| Q1 2023 | $8.6M | +341% |
| Q4 2022 | $2.7M | -69% |
| Q3 2022 | $2.7M | -39% |
| Q2 2022 | $3.9M | +189% |
| Q1 2022 | $2M | +189% |
ADAG's revenue is recovering but still below its 2021 peak: $2M last quarter, up 298% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1024% | N/A |
| Q4 2023 | -2289% | -1621 points |
| Q3 2023 | -2289% | -1621 points |
| Q2 2023 | -29% | +1196 points |
| Q1 2023 | -29% | +1196 points |
| Q4 2022 | -668% | -272 points |
| Q3 2022 | -668% | -272 points |
| Q2 2022 | -1225% | +1535 points |
ADAG's operating margin was −1024% last quarter, down 995 points from the same quarter a year ago.
ADAG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$14.9M | -$3.8M |
| Q4 2025 | -$4.5M | +$11.8M |
| Q2 2025 | -$11.1M | -$4.4M |
| Q4 2024 | -$16.3M | -$1.3M |
| Q2 2024 | -$6.7M | +$36K |
| Q1 2024 | -$6.7M | +$36K |
| Q4 2023 | -$15.1M | -196% |
| Q3 2023 | $0 | -100% |
ADAG has burned cash in most quarters: −$47M over the past year, against −$28M the year before.
ADAG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -23% | -13.7M shares |
| 1 year | +28% | +10M shares |
| 3 years | +30% | +10.4M shares |
| 5 years | +65% | +17.8M shares |
| Available history | +367% | +35.6M shares |
ADAG has 45M diluted shares, up 28% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
ADAG Net Leverage
ADAG's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ADAG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 9.4 | Oversold |
ADAG's weekly RSI is 36 (neutral) and its Stochastic is 9 (oversold).
ADAG PE vs Healthcare Sector
ADAG has no meaningful PE right now: it lost money over the past year.
ADAG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.44 | 18% below |
| 20 week MA | $3.21 | 38% below |
| 50 week MA | $3.15 | 37% below |
| 100 week MA | $2.51 | 20% below |
| 200 week MA | $2.30 | 13% below |
ADAG is in a downtrend: it's below all five of its weekly moving averages, and 13% below its 200-week average.
ADAG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $27.7 | $7.50 | -73% |
| 2022 | $7.50 | $1.26 | -83% |
| 2023 | $1.26 | $1.93 | +53% |
| 2024 | $1.93 | $1.96 | +1.6% |
| 2025 | $1.96 | $1.78 | -9.2% |
| 2026 YTD | $1.78 | $2.00 | +12% |
ADAG has finished lower in three of the last five years. It's up 12% so far in 2026.